Advertisement

The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7<sup>th</sup> Meeting of AIRO – Young Members Working Group (AIRO Giovani)

Abstract

Stereotactic ablative radiotherapy is a modern cancer treatment strategy able to deliver highly focused radiation in one or a few fractions with a radical intent in several clinical settings. Young radiation oncologists need a constant and tailored update in this context to improve patient care in daily clinical practice. A recent meeting of AIRO Giovani (AIRO - Young Members Working Group) was specifically addressed to this topic, presenting state-of-the-art knowledge, based on the latest evidence in this field. Highlights of the congress are summarized and presented in this report, including thorough contributions of the speakers dealing with the role of stereotactic ablative radiotherapy in both oncological and non-oncological diseases, divided according to anatomical and clinical scenarios: intra-cranial settings (brain malignant primary tumors, metastases, benign tumors and functional disorders) and extra-cranial indications (lung primary tumors and metastases, thoracic re-irradiation, liver, lymph node and bone metastases, prostate cancer). With literature data discussed during the congress as a background, stereotactic ablative radiotherapy has proved to be a consolidated treatment approach in specific oncological and non-oncological scenarios, as well as a promising option in other clinical settings, requiring a further prospective validation in the near future. We herein present an updated overview of stereotactic ablative radiotherapy use in the clinic.

Tumori 2014; 100(6): e214 - e229

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1778.19280

Authors

Pierfrancesco Franco, Berardino De Bari, Patrizia Ciammella, Alba Fiorentino, Silvia Chiesa, Dante Amelio, Valentina Pinzi, Pierluigi Bonomo, Stefano Vagge, Michele Fiore, Tiziana Comito, Agnese Cecconi, Gianluca Mortellaro, Alessio Bruni, Marco Trovo’, Andrea Riccardo Filippi, Daniela Greto, Filippo Alongi on behalf of AIRO Giovani (Italian Association of Radiation Oncology, You

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Franco, Pierfrancesco [PubMed] [Google Scholar]
    Department of Oncology, Radiation Oncology, University of Torino, Turin, Italy
  • De Bari, Berardino [PubMed] [Google Scholar]
    Radiation Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
  • Ciammella, Patrizia [PubMed] [Google Scholar]
    Radiotherapy Unit, Department of Advanced Technologies, Azienda Ospedaliera “Arcispedale Santa Maria Nuova”, IRCCS, Reggio Emilia, Italy
  • Fiorentino, Alba [PubMed] [Google Scholar]
    Radiation Oncology, Ospedale Sacro Cuore-Don Calabria, Negrar (Verona), Italy
  • Chiesa, Silvia [PubMed] [Google Scholar]
    Radiotherapy Institute, Università Cattolica del Sacro Cuore, Rome, Italy
  • Amelio, Dante [PubMed] [Google Scholar]
    Proton Therapy Center, Trento Hospital, Trento, Italy
  • Pinzi, Valentina [PubMed] [Google Scholar]
    Neurosurgery Department, Radiotherapy Unit, Neurological Institute Carlo Besta Foundation, Milan, Italy
  • Bonomo, Pierluigi [PubMed] [Google Scholar]
    Department of Oncology, Radiation Oncology, AOU Careggi, Florence, Italy
  • Vagge, Stefano [PubMed] [Google Scholar]
    Department of Radio-Oncology, IRCCS AOU San Martino IST, National Institute for Cancer Research, Genoa, Italy
  • Fiore, Michele [PubMed] [Google Scholar]
    Radiotherapy Unit, Campus Biomedico University, Rome, Italy
  • Comito, Tiziana [PubMed] [Google Scholar]
    Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center, Rozzano (MI), Italy
  • Cecconi, Agnese [PubMed] [Google Scholar]
    Advanced Radiotherapy Center, European Institute of Oncology, Milan, Italy
  • Mortellaro, Gianluca [PubMed] [Google Scholar]
    Radiotherapy Department, ARNAS Civico Hospital, Palermo, Italy
  • Bruni, Alessio [PubMed] [Google Scholar]
    Radiation Oncology Department, AOU Policlinico of Modena, Modena, Italy
  • Trovo’, Marco [PubMed] [Google Scholar]
    Department of Radiation Oncology, Centro di Riferimento Oncologico of Aviano, Pordenone, Italy
  • Filippi, Andrea Riccardo [PubMed] [Google Scholar]
    Department of Oncology, Radiation Oncology, University of Torino, Turin, Italy
  • Greto, Daniela [PubMed] [Google Scholar]
    Department of Radiation Oncology, University of Florence, Florence, Italy
  • Alongi on behalf of AIRO Giovani (Italian Association of Radiation Oncology, You, Filippo [PubMed] [Google Scholar]
    Radiation Oncology, Ospedale Sacro Cuore-Don Calabria, Negrar (Verona), Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.